EMERYVILLE, Calif, March 17, 2016 -- Biossance™, the pioneer of sustainable solutions in beauty from Amyris, Inc. (Nasdaq:AMRS), announced today the latest new product in the Biossance skin care brand line ─ The Refresher Makeup Removing Cloths ─ marking the fourth product announced since brand launch in June 2015. Now available at biossance.com and HSN (hsn.com), The Refresher is a package of biodegradable cleansing cloths enriched with an all-natural antioxidant blend of ingredients that gently remove makeup and impurities without leaving skin tight or dry.
|
|||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/13238941-ffca-41f1-a962-2d570dc4b34c
Moisturizing Cleansing and Biodegradable ─ Safe on Your Skin and Safe for the Planet
The Refresher cloths are infused with the unique moisturizing power of Amyris’s squalane for ultimate smoothness and hydration along with hemisqualane for gentle yet effective cleansing and makeup-removing properties. And, each cloth is generously enriched with a unique antioxidant blend composed of rice bran, rosemary leaf and sunflower extracts, and vitamin E providing powerful antioxidant protection while naturally soothing the skin and delivering a beautiful radiant glow. They are suitable for all skin types, contain carefully selected ingredients, and are biodegradable so they’re safe on your skin and safe for the planet.
Clinical validation tests conducted for The Refresher have found that 100% of women using the product agreed it is gentle to use around the eye area and does not leave skin feeling tight or dry and 95% agreed the product removes makeup in just a few strokes.
*Ideal for all skin types *Dermatologist tested *Ophthalmologist tested *No parabens
*No synthetic fragrance *Non-toxic *No phthalates *No mineral oil
About Biossance
Biossance™ pioneered sustainable 100% plant-based squalane to replenish your skin and enhance your biological beauty. The squalane-based brand was created in response to the prevalent use of squalane derived from sharks as an emollient in cosmetic products, creating devastating environmental impact. We’ve designed our line of squalane-based products to empower and inform you, so you can trust that what you are putting on your skin is safe. We won’t compromise, so we hand-select the most effective ingredients and avoid those that are potentially harmful to you or the planet. The full Biossance skin care and beauty collection can be found at http://biossance.com.
About Amyris
Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.
Amyris, the Amyris logo, and Biossance are trademarks or registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
Contacts: Elle Communications Delilah Owens (516) 445-0246 [email protected] or Lily Taban (661) 607-9397 [email protected] Amyris, Inc. Peter DeNardo Director, Investor Relations and Corporate Communications (510) 740-7481 [email protected] [email protected]


ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



